Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$449M |
| 2 |
GE Aerospace
GE
|
+$255M |
| 3 |
Canadian National Railway
CNI
|
+$237M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$212M |
| 5 |
Wynn Resorts
WYNN
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$403M |
| 2 |
AbbVie
ABBV
|
+$241M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$218M |
| 4 |
Comcast
CMCSA
|
+$157M |
| 5 |
LyondellBasell Industries
LYB
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.63% |
| 2 | Financials | 13.7% |
| 3 | Technology | 9.85% |
| 4 | Industrials | 9.84% |
| 5 | Energy | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verizon
VZ
$195B
| $1.72B | 2.91% |
36,818,448
+3,695,400
| +11% | +$181M |
|
2
Microsoft
MSFT
$3.71T
| $1.61B | 2.73% |
36,494,905
+1,931,538
| +6% | +$88.1M |
|
3
Texas Instruments
TXN
$254B
| $1.29B | 2.18% |
24,982,595
+965,006
| +4% | +$53.3M |
|
4
ConocoPhillips
COP
$140B
| $1.14B | 1.94% |
18,598,975
+1,173,516
| +7% | +$76.5M |
|
5
Wells Fargo
WFC
$265B
| $1.08B | 1.84% |
19,265,300
+1,935,600
| +11% | +$108M |
|
6
Coca-Cola
KO
$374B
| $1.03B | 1.74% |
26,133,433
+1,290,088
| +5% | +$52.5M |
|
7
Philip Morris
PM
$293B
| $894M | 1.52% |
11,149,306
+1,036,300
| +10% | +$85.3M |
|
8
CME Group
CME
$95B
| $852M | 1.44% |
9,151,795
| – | – |
|
9
Lockheed Martin
LMT
$135B
| $840M | 1.42% |
4,518,829
+477,100
| +12% | +$91.9M |
|
10
Chevron
CVX
$371B
| $836M | 1.42% |
8,669,900
-419,050
| -5% | -$44M |
|
11
Home Depot
HD
$349B
| $829M | 1.41% |
7,460,937
+115,467
| +2% | +$12.9M |
|
|
12
Bristol-Myers Squibb
BMY
$131B
| $823M | 1.4% |
12,370,291
-3,311,394
| -21% | -$218M |
|
13
Newell Brands
NWL
$2.56B
| $793M | 1.35% |
19,300,493
+993
| +0% | +$39.8K |
|
14
Pfizer
PFE
$149B
| $782M | 1.33% |
24,573,937
+27,088
| +0.1% | +$883K |
|
15
Procter & Gamble
PG
$342B
| $755M | 1.28% |
9,652,161
+1,268,161
| +15% | +$102M |
|
16
Goldman Sachs
GS
$301B
| $750M | 1.27% |
3,593,817
+177,517
| +5% | +$36.2M |
|
17
Enbridge
ENB
$113B
| $740M | 1.26% |
15,828,246
+1,449,476
| +10% | +$72M |
|
18
Gilead Sciences
GILD
$162B
| $735M | 1.25% |
6,278,500
| – | – |
|
19
DuPont de Nemours
DD
$19.5B
| $714M | 1.21% |
5,511,139
+987,203
| +22% | +$128M |
|
|
20
AbbVie
ABBV
$431B
| $702M | 1.19% |
10,451,196
-3,695,700
| -26% | -$241M |
|
|
21
Merck
MRK
$317B
| $654M | 1.11% |
12,030,390
-7,192,943
| -37% | -$403M |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $631M | 1.07% |
5,924,321
+992,821
| +20% | +$115M |
|
23
Boeing
BA
$184B
| $596M | 1.01% |
4,294,400
+847,800
| +25% | +$124M |
|
|
24
Eli Lilly
LLY
$1.06T
| $587M | 0.99% |
7,029,300
+5,889,300
| +517% | +$449M |
|
25
JPMorgan Chase
JPM
$947B
| $564M | 0.96% |
8,316,800
+1,289,100
| +18% | +$84.2M |
|
Similar funds
Capital International Investors's Q2 2015 Portfolio in Review
As of Q2 2015, Capital International Investors held 274 positions worth $59B, up 7.3% from $55B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Capital International Investors deployed $4.18B of net new capital in Q2 2015, opening 20 new positions and adding to 113 existing holdings. Its largest new stake was Canadian National Railway: 3,775,548 shares worth $218M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Merck, an estimated $403M trimmed.
- Capital International Investors's largest Q2 2015 buy was Canadian National Railway: 3,775,548 shares worth $218M.
- Capital International Investors added most to Eli Lilly in Q2 2015, an estimated $449M increase.
- Capital International Investors's biggest Q2 2015 reduction was Merck, cutting an estimated $403M.
- Capital International Investors fully exited Leggett & Platt in Q2 2015, selling an estimated $81.5M.
- Capital International Investors's ten largest holdings make up 19% of its $59B portfolio in Q2 2015.
- Capital International Investors opened 20 new positions and closed 16 in Q2 2015.
- Capital International Investors's portfolio value rose 7.3% quarter-over-quarter to $59B.
Based on Capital International Investors's 13F filing for Q2 2015, filed 14 Aug 2015.